GE to target Brazil with new molecular breast imaging system
This article was originally published in Clinica
Executive Summary
GE Healthcare is eyeing Brazil as the first market for its newly launched Discovery NM750b molecular breast imaging system, intended to help screen high-risk women for breast cancer. The company unveiled the device for the first time yesterday, at the annual meeting of the European Association of Nuclear Medicine, currently being held in Birmingham, UK, from 15-19 October.